Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Haycox

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
BMJ (Clinical Research Ed.)|February 5, 1999
Clinical guidelines-the hidden costsA Haycox, A Bagust, T Walley
Iranian Journal of Public Health|November 1, 2012
Health care financing in iran; is privatization a good solution?M Davari, A Haycox, T Walley
BMJ (Clinical Research Ed.)|November 2, 1996
Cost effectiveness of lowering cholesterol. Study did not take account of confoundersA Haycox, S Barton, T Walley
British Journal of Clinical Pharmacology|June 1, 1997
Pharmacoeconomics: integrating economic evaluation into clinical trialsA Haycox, M Drummond, T Walley
Iranian Journal of Public Health|November 30, 2012
The Iranian health insurance system; past experiences, present challenges and future strategiesM Davari, A Haycox, T Walley
Lancet (London, England)|July 25, 1981
Investigation of suspect dementiaJ A Haycox, J P Blass, C Shamoian
The British Journal of Dermatology|January 20, 1999
A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practiceK M Humphrey, M J Cork, A Haycox
Alimentary Pharmacology & Therapeutics|November 3, 1998
Review article: current practice and future perspectives in detection and diagnosis of pancreatic cancerA Haycox, M Lombard, J Neoptolemos, et al.
Health Technology Assessment (Winchester, England)|September 23, 2003
Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of ageS Allsup, M Gosney, A Haycox, et al.
Pharmacoeconomics|May 27, 1999
Development of an economic model for the management of upper gastrointestinal disease in primary care. Preliminary findingsA Haycox, M Butterworth, T Walley, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
BMJ (Clinical Research Ed.)|February 5, 1999
Clinical guidelines-the hidden costsA Haycox, A Bagust, T Walley
Iranian Journal of Public Health|November 1, 2012
Health care financing in iran; is privatization a good solution?M Davari, A Haycox, T Walley
BMJ (Clinical Research Ed.)|November 2, 1996
Cost effectiveness of lowering cholesterol. Study did not take account of confoundersA Haycox, S Barton, T Walley
British Journal of Clinical Pharmacology|June 1, 1997
Pharmacoeconomics: integrating economic evaluation into clinical trialsA Haycox, M Drummond, T Walley
Iranian Journal of Public Health|November 30, 2012
The Iranian health insurance system; past experiences, present challenges and future strategiesM Davari, A Haycox, T Walley
Lancet (London, England)|July 25, 1981
Investigation of suspect dementiaJ A Haycox, J P Blass, C Shamoian
The British Journal of Dermatology|January 20, 1999
A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practiceK M Humphrey, M J Cork, A Haycox
Alimentary Pharmacology & Therapeutics|November 3, 1998
Review article: current practice and future perspectives in detection and diagnosis of pancreatic cancerA Haycox, M Lombard, J Neoptolemos, et al.
Health Technology Assessment (Winchester, England)|September 23, 2003
Cost-benefit evaluation of routine influenza immunisation in people 65-74 years of ageS Allsup, M Gosney, A Haycox, et al.
Pharmacoeconomics|May 27, 1999
Development of an economic model for the management of upper gastrointestinal disease in primary care. Preliminary findingsA Haycox, M Butterworth, T Walley, et al.
Pageof 8